American HealthCare Capital is proud to introduce a beautiful, well-established private practice and sleep center located in the heart of Silicon Valley, California. This full-service sleep disorder center is fully accredited by the American Association of Sleep Medicine and is one of only a few sleep centers serving the Silicon Valley area that is not affiliated with a large hospital. The sleep lab for sale offers electronic health records (EHR) integrated physician consultations, diagnostic testing, and sleep medicine therapeutics to evaluate and treat all sleep disorders.Diagnostic testing services include in-lab/home sleep testing (PSG/MSLT/HST), as well as daytime testing.
The payer mix is 70% commercial insurance and 30% Medicare. Gross revenues have been consistent in the $700,000 range over the past few years. In 2021, they gross $776,918 with an adjusted EBITDA of $493,382. In 2022, they are on pace to exceed $700,000 in gross reve-nues with an adjusted EBITDA margin over 50%.
The company has a strong internet presence with a great reputation within the medical community. Its patient base continues to grow through self-referrals, as well as referrals from primary care physicians, psychiatrists, occupational medicine physicians, endocrinologists, and cardiologists.
The center has 2,200 sq ft with a monthly rent of approximately $10,000. The seller owns the real estate, so lease negotiation will be possible. The owner is able to stay active as the Medical Director or in an employed clinical role.
The asking price for this opportunity is $500,000 which includes all the equipment, furniture, and fixtures. The price has been reduced for quick sale. This is an exceptional opportunity to take over a thriving practice in the heart of Silicon Valley.
If you would like to learn more, please use the link on the right-hand side of the page to execute our NDA. You will need to copy the Listing Code (Example: TXMC1A) and Listing Title (Example: $1 Million Home Health Agency in Texas) from the summary above to complete the NDA.